肾活检肾硬化的年龄相关阈值与青年成人阈值及其对慢性肾脏病的预后意义
该研究基于3020例活体肾供者的肾活检形态计量学,建立了青年(18-29岁)阈值和按年龄分层的第95百分位阈值。在1363例肾肿瘤患者和314例原生肾病患者的验证中,仅年龄相关阈值对进展性慢性肾脏病具有预后价值,提示年龄相关阈值优于单一青年阈值。
要点
- 肾硬化年龄相关阈值在老年(≥70岁)正常血压供者中较青年(18-29岁)高7.1至36倍。
- 仅年龄相关阈值(而非青年阈值)可预测肾肿瘤或原生肾病患者进展性慢性肾脏病风险。
- 肾硬化仅在超出年龄预期范围时才与进展性慢性肾脏病风险升高相关。
核心结论
- 年龄相关肾硬化阈值似乎优于单一青年阈值,用于识别临床相关慢性肾脏病。
- 进展性慢性肾脏病风险升高仅见于肾硬化超出年龄预期范围时。
研究设计与样本
- 对3020例活体肾供者、1363例肾肿瘤患者和314例原生肾病患者进行肾活检图像的形态计量学分析。
- 利用正常血压供者定义青年(18-29岁)阈值和按年龄(大致按十年)的第95百分位阈值。
主要发现
- 最年轻组(18-29岁)至最年长组(≥70岁)的第95百分位:全球硬化肾小球百分比为1.7%至16%,间质纤维化及肾小管萎缩百分比为0.18%至6.5%,间质纤维化及肾小管萎缩灶密度为8.2至59.3个/cm²。
- 肾硬化「与青年相比正常」者与「年龄正常但较青年异常」者的进展性慢性肾脏病风险无差异。
- 在两个队列中,全球硬化肾小球百分比、间质纤维化及肾小管萎缩百分比或间质纤维化及肾小管萎缩灶密度超出年龄正常范围者,进展性慢性肾脏病风险显著更高。
关键数值与推荐
- 年轻年龄阈值为18-29岁正常血压供者的第95百分位:全球硬化肾小球百分比1.7%,间质纤维化及肾小管萎缩百分比0.18%,间质纤维化及肾小管萎缩灶密度8.2个/cm²。
- 年龄相关阈值为各年龄组正常血压供者的第95百分位,老年组(≥70岁)较青年组高7.1至36倍。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
SIGNIFICANCE STATEMENT: Nephrosclerosis (glomerulosclerosis, interstitial fibrosis, and tubular atrophy) is the defining pathology of both kidney aging and CKD. Optimal thresholds for nephrosclerosis that identify persons with a progressive disease are unknown. This study determined a young-age threshold (18-29 years) and age-based 95th percentile thresholds for nephrosclerosis on the basis of morphometry of kidney biopsy sections from normotensive living kidney donors. These thresholds were 7.1-fold to 36-fold higher in older (70 years or older) versus younger (aged 18-29 years) normotensive donors. Age-based thresholds, but not young-age threshold, were prognostic for determining risk of progressive CKD among patients who underwent a radical nephrectomy or a for-cause native kidney biopsy, suggesting that age-based thresholds are more useful than a single young-age threshold for identifying CKD on biopsy. BACKGROUND: Nephrosclerosis, defined by globally sclerotic glomeruli (GSG) and interstitial fibrosis and tubular atrophy (IFTA), is a pathology of both kidney aging and CKD. A comparison of risk of progressive CKD using aged-based thresholds for nephrosclerosis versus a single young-adult threshold is needed. METHODS: We conducted morphometric analyses of kidney biopsy images for %GSG, %IFTA, and IFTA foci density among 3020 living kidney donors, 1363 patients with kidney tumor, and 314 patients with native kidney disease. Using normotensive donors, we defined young-age thresholds (18-29 years) and age-based (roughly by decade) 95th percentile thresholds. We compared age-adjusted risk of progressive CKD (kidney failure or 40% decline in eGFR) between nephrosclerosis that was "normal compared with young," "normal for age but abnormal compared with young," and "abnormal for age" in patients with tumor and patients with kidney disease. RESULTS: The 95th percentiles in the youngest group (18-29 years) to the oldest group (70 years or older) ranged from 1.7% to 16% for %GSG, 0.18% to 6.5% for %IFTA, and 8.2 to 59.3 per cm 2 for IFTA foci density. Risk of progressive CKD did not differ between persons with nephrosclerosis "normal compared with young" versus "normal for age but abnormal compared with young." Risk of progressive CKD was significantly higher with %GSG, %IFTA, or IFTA foci density that was abnormal versus normal for age in both cohorts. CONCLUSIONS: Given that increased risk of progressive CKD occurs only when nephrosclerosis is abnormal for age, age-based thresholds for nephrosclerosis seem to be better than a single young-age threshold for identifying clinically relevant CKD.
引用
- Asghar MS, Denic A, Mullan AF, et al. Age-Based Versus Young-Adult Thresholds for Nephrosclerosis on Kidney Biopsy and Prognostic Implications for CKD. J Am Soc Nephrol. 2023. PMID: 37254246. doi:10.1681/ASN.0000000000000171
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。